Remyelination occurs as extensively but more slowly in old rats compared to young rats following gliotoxin-induced CNS demyelination - PubMed (original) (raw)
Comparative Study
Remyelination occurs as extensively but more slowly in old rats compared to young rats following gliotoxin-induced CNS demyelination
S A Shields et al. Glia. 1999 Oct.
Erratum in
- Glia 2000 Jan 1;29(1):102
Abstract
Age is one of the many factors that influence remyelination following CNS demyelination, although it is not clear whether it is the extent or rate of remyelination that is affected. To resolve this issue we have compared remyelination in young and old adult rat CNS following gliotoxin-induced demyelination. Remyelination of areas of ethidium bromide-induced demyelination in the caudal cerebellar peduncle reached completion by 4 weeks in young adult rats (2 months) but was not complete until 9 weeks in old adult rats (9-12 months). We have also shown that remyelination of lysolecithin-induced demyelination in the spinal white matter of old adult rats (18 months) can be extensive, with longer survival times (8 weeks) than have previously been examined. Thus, it is the rate rather than the extent of remyelination that changes in the ageing CNS. These results have important implications for understanding the mechanisms of remyelination, indicating that remyelination need not occur rapidly for it to be extensive. The capacity for the process of remyelination to continue over many weeks must also be borne in mind when assessing remyelination-enhancement strategies either by transplantation or promotion of endogenous mechanisms.
Copyright 1999 Wiley-Liss, Inc.
Similar articles
- Females remyelinate more efficiently than males following demyelination in the aged but not young adult CNS.
Li WW, Penderis J, Zhao C, Schumacher M, Franklin RJ. Li WW, et al. Exp Neurol. 2006 Nov;202(1):250-4. doi: 10.1016/j.expneurol.2006.05.012. Epub 2006 Jun 22. Exp Neurol. 2006. PMID: 16797535 - Failure of remyelination in areas of demyelination produced in the spinal cord of old rats.
Gilson J, Blakemore WF. Gilson J, et al. Neuropathol Appl Neurobiol. 1993 Apr;19(2):173-81. doi: 10.1111/j.1365-2990.1993.tb00424.x. Neuropathol Appl Neurobiol. 1993. PMID: 8316337 - Remyelination in experimental models of toxin-induced demyelination.
Blakemore WF, Franklin RJ. Blakemore WF, et al. Curr Top Microbiol Immunol. 2008;318:193-212. doi: 10.1007/978-3-540-73677-6_8. Curr Top Microbiol Immunol. 2008. PMID: 18219819 Review. - The role of oligodendrocytes and oligodendrocyte progenitors in CNS remyelination.
Keirstead HS, Blakemore WF. Keirstead HS, et al. Adv Exp Med Biol. 1999;468:183-97. doi: 10.1007/978-1-4615-4685-6_15. Adv Exp Med Biol. 1999. PMID: 10635029 Review.
Cited by
- Understanding the spectrum of non-motor symptoms in multiple sclerosis: insights from animal models.
Weerasinghe-Mudiyanselage PDE, Kim JS, Shin T, Moon C. Weerasinghe-Mudiyanselage PDE, et al. Neural Regen Res. 2024 Jan;19(1):84-91. doi: 10.4103/1673-5374.375307. Neural Regen Res. 2024. PMID: 37488849 Free PMC article. Review. - CDP-choline to promote remyelination in multiple sclerosis: the need for a clinical trial.
Gudi V, Grieb P, Linker RA, Skripuletz T. Gudi V, et al. Neural Regen Res. 2023 Dec;18(12):2599-2605. doi: 10.4103/1673-5374.373671. Neural Regen Res. 2023. PMID: 37449595 Free PMC article. Review. - Remyelination in animal models of multiple sclerosis: finding the elusive grail of regeneration.
Packer D, Fresenko EE, Harrington EP. Packer D, et al. Front Mol Neurosci. 2023 Jun 28;16:1207007. doi: 10.3389/fnmol.2023.1207007. eCollection 2023. Front Mol Neurosci. 2023. PMID: 37448959 Free PMC article. Review. - Age-dependent decline in remyelination capacity is mediated by apelin-APJ signaling.
Ito M, Muramatsu R, Kato Y, Sharma B, Uyeda A, Tanabe S, Fujimura H, Kidoya H, Takakura N, Kawahara Y, Takao M, Mochizuki H, Fukamizu A, Yamashita T. Ito M, et al. Nat Aging. 2021 Mar;1(3):284-294. doi: 10.1038/s43587-021-00041-7. Epub 2021 Mar 15. Nat Aging. 2021. PMID: 37118408 - Mechanisms of Demyelination and Remyelination Strategies for Multiple Sclerosis.
Zhao X, Jacob C. Zhao X, et al. Int J Mol Sci. 2023 Mar 28;24(7):6373. doi: 10.3390/ijms24076373. Int J Mol Sci. 2023. PMID: 37047344 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical